Seventy-six (7.5 %) of 1007 clinical isolates of Escherichia coli, Shigella and Salmonella from patients in Saadi Hospital, Shiraz, Iran, produced colicins of group E. The majority of isolates produced colicin E l and none produced colicins E2 or E3. This is the first report of the production of colicin E4Horak by strains of Salmonella and of colicins E5 and E6 by strains other than Shigella sonnei, and only the second report of the isolation of any strain producing colicin E7.
B. Strains active on both indicators were considered as producing either one or more non-E colicins of group A or both E and non-E colicins. Group E colicins were typed by their activity, or lack of it, on seven E-immune indicator strains. each immune to one type of E colicin. i.e. E 1 to E7.
Colicin rransfer. Transfer of the multiple E colicins (or a new type of E colicin) produced by E . coli strains 44 and 3 I0 to E. coli CL 142 was performed using strain Stm470, which carries an incomplete form of R Utrecht (van Embden et al., 1976) . as 'helper'. The mixture of organisms, which contained 1-0 mg trypsin ml-', was incubated at 37 " C for 24 h. Transconjugants were then selected on blood agar base (Oxoid) containing 1 mg streptomycin mlk I.
R E S U L T S A N D D I S C U S S I O N
Among the clinical isolates examined, 15% of E. coli strains, 15.5% of Shigella strains and 10% of Salmonella strains produced one or more colicins (Table 1) . This incidence is similar to previous reports of 20 to 40% among E. coli strains from clinical material (Fredericq, 1948; Vosti, 1968) but differs somewhat from the reported 50% or more among Shigella strains (Papavassiliou et al., 1964) and 5 % among Salmonella strains (Males, 1978) .
Of the 1007 strains tested for colicin production, 144 (14.3%) were found to be colicinogenic (Table 1) : 76 (7.5%) strains produced only colicin(s) of group E, 54 (5.4%) produced only group B colicin(s) (Davies & Reeves, 1975a) and 9 (0.9%) produced one or more non-E colicins of group A (Davies & Reeves, 19756) or combinations of E and non-E colicins.
Two of the E. coli isolates, strains 44 and 310, produced only E colicin(s) which were active on all the seven E-immune indicator strains. The results of the conjugation crosses between strain 310 and strain CL142 indicated that strain 310 produced colicin E6 and at least one additional E colicin, probably El, E2 or E7. Attempts to transfer the colicin plasmid(s) carried by E. coli strain 44 were unsuccessful.
Six strains of E. coli, two strains of group A Salmonella and one strain of Sh.Jexneri produced colicin E4Horak, and one E. coli strain produced E4 and Ia. This finding is of interest since Barker (1980) in a study on colicinogeny in S . typhimurium found only E l and E2 colicins among the 448 1 strains that she examined. Colicin E4Horak has been reported as being only produced by strains of Sh. sonnei (Horak, 1975) and two strains of E. coli (Males & Stocker, 1982) .
Colicins E5 and E6 have also been reported as being produced only by strains of Sh. sonnei (Horak, 1975; Males & Stocker, 1982) . Among the clinical isolates examined were found, for the first time, strains of E. coli which produced colicins E5 and E6 and strains of S . typhimurium which produced colicin E5. The two E7 colicins, E7-212 and E7-KBB, produced by E. coli strains 212 and KBB, are only the second and the third reported colicins of type E7. The first identified E7 colicin, E7-K3 17, is produced by Fredericq's strain CL137 (=K 12-3 17) . This colicin, formerly thought to be E2, has recently been shown by Males & Stocker (1980) to be an E colicin of a previously undescribed type.
Most of the colicinogenic isolates examined were either poor indicators showing only narrow or faint zones of inhibition with any E-producing strains, or were totally insensitive to all E colicins and phage BF23. The two E7-producing strains, E. coli strains 212 and KBB, however, were sensitive to all the E colicins except colicin E7-K3 17 produced by E. coli K 12-3 17. Unexpectedly, however, these two strains were insensitive to phage BF23. Some E . coli K12 derivatives carrying ColIb-P9 (Strobe1 & Nomura, 1966) Stocker, 1980) restrict phage BF23 in the sense that they interfere with the multiplication of the phage even though adsorption and penetration are normal. Although the presence of a restricting plasmid could not be demonstrated in strains 212 and KBB, it may well be that these strains also carry such plasmids. Colicin E2 and E7 (but not other E colicins) produce 'double zones' of inhibition against K12 btuB+ indicator strains carrying plasmids of types ColE4, ColE5 or ColE6. Males & Stocker (1982) have attributed the 'double zone' phenomenon to increased sensitivity of these indicators to colicins E2 and E7. Escherichia coli strains 212 and KBB, both isolated in Shiraz, producing colicin E7, likewise produced 'double zones' on K 12 btuB+ strains carrying ColE4, ColE5 or ColE6. Thus the two new E7 colicins behave like the original E7 colicin, E7-K3 17, in this respect.
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